1 1

Organic Skin Care Cream 1.6 oz (50ml) - chcgreens

Organic Skin Care Cream 1.6 oz (50ml) - chcgreens

$99.00 USD
$99.00 USD
Sale Sold out
  • GMO FREE
  • NATURAL & ORGANIC

CG brings nature's touch to your daily skincare routine. Designed to soothe and nourish, this organic cream is made with natural and organic ingredients carefully chosen to promote healthy-looking skin.

Crafted with care and quality, CG cream offers a gentle, calming sensation, perfect for everyday use. Enjoy the confidence of choosing a product backed by a commitment to purity and sustainability.

  • 10% OFF Every Order
  • Cancel, Skip, or Pause Anytime, with a click of a button.
  • Fast Priority Shipping
  • 180-Day Money-Back Guarantee
  • 100% Refund Policy
  • 5-8 Day Shipping
  • Secure Payments
  • 30 day Satisfaction guarantee

I’ve been dealing with skin discomfort and have tried many products. After using this, I noticed a soothing effect shortly after application. It rubs in smoothly and provides noticeable comfort. I’m happy with my purchase.

Dennies verified buyer

Ingredients

Ingredients: Juniper, Rosa Damascena, Neem, Yarrow, Geranium, Tea tree, eucalyptus, Bergamot, Lavender patchouli,
Vitamin E, Grape seeds oil,
Shea butter

Ingredients Explanations

Tea Tree Oil: Valued for its refreshing properties, tea tree oil has been traditionally used in skincare routines.
Lavender Oil: Renowned for its soothing aroma, lavender oil is often included in products designed for comfort and relaxation.
Eucalyptus Oil: Known for its invigorating scent, eucalyptus oil is frequently incorporated into wellness formulations.
Neem Oil: Esteemed for its rich heritage in traditional skincare practices, neem oil is a versatile botanical extract.
Rosemary Oil: Celebrated for its aromatic qualities, rosemary oil is a popular choice in natural skincare products.
Vitamin E: Recognized as a skin-conditioning agent, Vitamin E is widely used in formulations to support healthy-looking skin.
Shea Butter: Known for its hydrating properties, shea butter is a staple in products aimed at nourishing the skin.
Zinc: Included in many skincare formulations, zinc supports the maintenance of balanced and healthy-looking skin.

These naturally derived ingredients are thoughtfully selected to complement a holistic skincare approach.

How & Why it works

Most products are not powerful enough to penetrate deep into the skin. CHCgreens® is specially designed with a “unique transdermal technology” called CHCTANEOUS®.

Our ingredients are able to penetrate through the skin’s outermost layer and deliver powerful healing benefits to your skin in the areas that need it most.

View full details

Feature In

What is a 30-Day Satisfaction Guarantee?

We are confident in the quality of our treatments, which are crafted using clinically supported ingredients and freshly compounded at one of our trusted partner pharmacies. Our products have helped improve skin conditions for many users, and we believe you will experience positive results too.

We offer a 30-Day Satisfaction Guarantee, which allows you to try our products risk-free. If you are not satisfied with your purchase, simply reach out to our customer support team within 30 days from your purchase date, and we will assist you with a return or refund for the initial order.

To qualify for the 30-Day Satisfaction Guarantee, please note the following:

  • Consistent use of the product for the recommended period is necessary.
  • The guarantee applies only to the initial order of treatment, not refills or additional fees.
  • Side effects may occur with some products, but they are not an indication of a product's failure. Please consult with a healthcare professional if you have concerns.

High Quality Ingredients

How To Use:

1. Clean the affected area: Gently cleanse the skin and warm a small amount of CH cream between your fingers.
2. Apply a thin layer: Massage into the skin using circular motions and allow it to absorb for a minute or two.
3. Reapply as needed: Use 3-4 times daily or as required for comfort and relief.

 Add to Cart

What it Targets:

😞 Dull, Dry Skin
Hydrates and nourishes for softer, smoother skin.

🌫️ Fine Lines + Wrinkles
Improves the appearance of fine lines for a refreshed look.

💥 Redness + Irritation
Calms visible redness and soothes skin discomfort.

Add To Cart

Say Bye to Discomfort and Embarrassment

CHCGREENS® is crafted with high-quality, natural ingredients to provide comfort without the need for a prescription. Our advanced blend offers a unique formula designed to help support skin health.

CHCGREENS® is free from chemicals, artificial preservatives, lanolin, alcohol, parabens, petrochemicals, and fragrances.

Key Ingredients: Juniper, Rosa Damascena, Neem, Yarrow, and more...

Add to cart

Coming soon

Freshly Compounded, Potent, Customized For You

CHCgreens® contains a high concentration of active natural ingredients, carefully blended in a super absorbent certified organic base to help soothe and support comfort for various skin irritations.

  • JUNIPER 20 MG

    Juniper helps support the skin by promoting a healthy appearance and reducing the look of irritation.

  • ROSA DAMASCENA 30 MG

    Rosa Damascena (Rose) is known for its soothing properties, helping to support the skin’s natural appearance and promote a balanced feel.

  • NEEM TREE 50 MG

    Neem Tree Extracts are known for their gentle, soothing properties, supporting healthy skin and helping to maintain a balanced complexion.

  • YARROW 30 MG

    Yarrow is known for its calming properties, helping to soothe the skin and support its natural balance.

  • GERANIUM 25 MG

    Geranium is known for balancing oil production and promoting the skin's natural radiance.

  • TEE TREE 10 MG

    Tea Tree Oil helps purify and protect the skin, promoting a clearer and healthier appearance.

  • EUCALYPTUS 10 MG

    Eucalyptus refreshes and invigorates the skin by helping to cleanse pores, reduce irritation, and provide a soothing sensation.

  • +5 MORE Click "view the label"

    BERRGAMONG, LAVENDER, GRAPE SEEDS OIL, VITAMIN E, SHEA BUTTER
1 8
View The Label
×

This content is of the nature of an overview only and the information.

What Makes CHCGREENS the Best Choice for Skin Discomfort:

Here are 9 reasons why Gotucream is the top choice for soothing skin discomfort globally:

  • Results within Hours
    Unlike many other products, CHCGREENS offers noticeable improvement in skin comfort and appearance within hours of use.

  • Natural Ingredients
    CHCGREENS is crafted with a blend of active herbal ingredients, inspired by centuries of traditional herbal practices, offering a natural approach to skin care.

  • Backed by Science
    CHCGREENS uses ingredients that, alongside traditional use, have been studied for their safety and effectiveness, ensuring a thoughtful approach to natural skin care.

1 3

  • Certified Organic
    The active herbal ingredients in CHCGREENS are carefully blended in a natural cream base, free from harmful chemicals and parabens.

  • Effective Skin Absorption
    Thanks to its special formula, CHCGREENS is designed to be absorbed quickly by the skin, helping to support relief for insect bites more effectively.

  • Gentle and Natural Formula
    CHCGREENS is made with natural ingredients and has been well-tolerated by most users, offering a safer alternative to chemical-laden products.

1 3

  • Pleasant to Use
    CHCGREENS has a non-greasy texture and a mild, refreshing scent that enhances the application experience.

  • Suitable for Most Skin Types
    CHCGREENS is formulated for a wide range of skin types, but it’s always recommended to do a patch test first, especially for sensitive skin or children.

  • Premium Quality
    CHCGREENS is carefully formulated using a concentrated blend of natural ingredients, ensuring you receive a powerful ointment with no unnecessary additives.

1 3

Find Relief and Confidence

Why chcgreens® Works

Many products are not designed to effectively absorb into the skin. chcgreens® is crafted with advanced transdermal technology, helping to deliver its nourishing ingredients where they are most needed to support your skin’s natural health.

High Quality Ingredients

CHCGREENS® is crafted with high-quality natural ingredients, selected for their skin-nurturing properties, and is free from chemicals, artificial preservatives, lanolin, alcohol, parabens, petrochemicals, GMOs, or fragrances.

Active Ingredients:

  • Juniper (2%)
  • Rosa Damascena (1%)
  • Neem (3%)
  • Yarrow (1%)
  • Geranium (0.5%)
  • Tea Tree (2%)
  • Eucalyptus (1%)
  • Bergamot (1%)
  • Lavender (0.5%)
  • Patchouli (0.5%)
  • Vitamin E (0.5%)
  • Grape Seed Oil (1%)
  • Shea Butter (2%)

Other Ingredients:

  • Bergamot, Lavender, Grape Seed Oil, Vitamin E, Shea Butter

Supports Relief for Various Skin Concerns

Many skin concerns share common symptoms such as discomfort, dryness, and redness, which can impact overall skin health. CHCGREENS® is formulated with carefully selected ingredients to provide soothing care and support for skin prone to irritation, helping to improve comfort and hydration.

30 Day Money-Back Guarantee

We’re confident that you’ll be satisfied with CHCGREENS®! If you’re not completely happy with your purchase, you can return it within 30 days for a full refund—no questions asked.

FREQUENTLY ASKED QUESTIONS

How soon can I expect results?

CHCGREENS® is formulated to provide quick relief upon application. Many users report feeling an improvement shortly after use. However, the time needed to see complete results may vary depending on the severity of the condition, with some cases requiring a few weeks of consistent use for full relief.

How do I use chcgreens ointment?

Using CHCGREENS® ointment is simple. First, cleanse the affected area with plain water. Once the skin is dry, apply a small amount of ointment to the area and gently massage it in. Allow the cream to absorb into the skin. For best results, apply up to three times a day, or as needed.

Is ChcGreens Ointment safe for infants?

CHCGREENS® Ointment is formulated for topical use and is generally considered safe when applied to the skin. However, it should always be used under adult supervision to ensure it is not ingested. It is important to follow the directions for use and avoid contact with the eyes or mucous membranes.

Is payment for ChcGreens Ointment possible via health insurance?

CHCGREENS® Ointment is an over-the-counter product made with natural ingredients and does not require a prescription. As such, it is not covered by health insurance plans at this time.

Do you ship worldwide?

Yes, we are able to ship to all countries in the world, except a few sanctioned countries by the USA government.

How do I get a refund for ChcGreens Ointment?

Your ChcGreens Ointment purchase is  100% risk free via our 30 day money back guarantee. We have made the refund process as simple as possible. If you are not happy with your purchase for any reason whatsoever, just return the remaining portion of your cream in the jar that it came, along with the receipt (if available) and send it back to the address you received it from (see your package). We will instantly refund all your money.

An astonishing 200+ clinical studies! Scientific Research References

Following is a non-exhaustive list of clinical research behind the active herbal ingredients of chcgreens Ointment. The research is cited here as a reference only and is not meant to constitue a subsitute for professional medical advice.

  1. Coldren CD, Hashim P, Ali JM, Oh SK, Sinskey AJ, Rha C.  Planta Med 2003, 69:725-32
  2. Distante F, Scalise F, Ronaz C, Bonfigli A, Fluhry JW, Berardesca E.  International Journal of Cosmetic Science 2002, 24:81-7
  3. Haftek M, Mac Mary S, Bitoux MA, Creidi P, Seite S, Rougier A et al.  Exp Dermatol 2008, 17:946-52
  4. Lee J, Jung E, Kim Y, Park J, Park J, Hong S, Kim J, Hyun C, Kim YS, Park D.  Planta Med 2006, 72:324-8
  5. Ryu JS, Park SG, Kwak TJ, Chang MY, Park ME, Choi KH, Sung KH, Shin HJ, Lee CK, Kang YS, Yoon MS, Rang MJ, Kim SJ. Skin Res Technol 2005, 11:157-64
  6. Ahshawat MS, Saraf S. Int J Cosmet Sci 2008, 30:183-93
  7. Maquart FX, Bellon G, Giller P, Randoux A, Borel JP. Sem Hop Paris 1989, 65:1571-4
  8. Abdul Hamid A, Shah ZM, Muse R, Mohamed S. Urban Food Chem 2002, 77:465-9
  9. Gnanapragasam A, Ebenezar KK, Sathish V, Govindaraju P, Devaki T. Life Sci 2004, 76:585-97
  10. Jayashree G, Kurup Muraleedhara G, Sudarslal S, Jacob VB. Fitoterapia 2003, 74:431-4
  11. Subathra M, Shila S, Devi MA, Panneerselvam C. Exp Gerontol 2005, 40:707-15
  12. Zainol MK, Abd-Hamid A, Yusof S, Muse R. Urban. Food Chemistry 2003, 81:575-81
  13. Kimura Y, Sumiyoshi M, Samukawa K, Satake N, Sakanaka M. Eur J Pharmacol 2008, 584:415-23
  14. Liu M, Dai Y, Li Y, Luo Y, Huang F, Gong Z, Meng Q. Planta Med 2008, 74:809-15
  15. Mallol J, Belda MA, Costa D, Noval A, Sola M. Int J Cosm Sci 1991, 13:51-7
  16. Shukla A, Rasik AM, Jain GK, Shankar R, Kulshrestha DK, Dhawan BN. J Ethnopharmacol 1999, 65:1-11
  17. Suguna L, Sivakumar P, Chandrakasan G. Indian J Exp Biol 1996, 34:1208-11
  18. Wolfram S. Wien Med Wochenschr 1965, 115: 439-42
  19. Lee J, Jung E, Kim Y, Park J, Park J, Hong S, Kim J, Hyun C, Kim YS, Park D. Planta Med 2006, 72:324-8
  20. Maquart FX, Bellon G, Giller P, Randoux A, Borel JP. Sem Hop Paris 1989, 65:1571-4
  21. Lu L. et al. (2004). Int J Dermatol. 801-7.
  22. Chen YJ, Dai YS, Chen BF, Chang A, Chen HC, Lin YC et al. Biol Pharm Bull 1999, 22:703-6
  23. Hausen BM. Contact Dermatitis 1993, 29:175-79
  24. Klövekorn W, Tepe A, Danesch U. Int J Clin Pharmacol Ther 2007, 45(11):583-91.
  25. Somchit MN, Sulaiman MR, Zuraini A, Samsuddin L, Sonchit N, Israf DA, Moin S. Indian J Pharmacol 2004, 6:377-80
  26. Natarajan S, Paily PP. Ind J Dermatol 1973, 18(4):82-5
  27. Sampson JH, Raman A, Karlsen G, et al. Phytomedicine. 2001;8:230–5
  28. Somchit MN, Sulaiman MR, Zuraini A, Samsuddin L, Sonchit N, Israf DA, Moin S. Indian J Pharmacol 2004, 6:377-80
    De Sanctis MT, Belcaro G, Incandela L, Cesarone MR, Griffin M, Ippolito E, Cacchio M. Angiology 2001, 52(2):55-9
  29. Guseva G, Stravoitova MN, Mach ES. Ter Arkh. 1998;70:58–61.
  30. Allegra C, Pollari G, Criscuolo A, Bonifacio M, Tabassi D. Clin Ter 1981, 99(5):507-13 [Italian]
  31. Arpaia MR, Ferrone R, Amitrano M, Nappo C, Leonardo G, del Guercio R. Int J Clin Pharmacol Res 1990, 10:229-33
  32. Belcaro GV, Grimaldi R, Guidi G. Angiology 1990, 41(7):533-40
  33. Cataldi A, Gasbarro V, Viaggi R, Soverini R, Gresta E, Mascoli F. Minerva Cardioangiol 2001, 49(2):159-63 [Italian]
  34. Cataldi A, Gasbarro V, Viaggi R, Soverini R, Gresta E, Mascoli F. Minerva Cardioangiol 2001, 49(2):159-63 [Italian]
  35. Cesarone MR, Belcaro G, De Sanctis MT, Incandela L, Cacchio M, Bavera P, Ippolito E, Bucci M, Griffin M, Geroulakos G, Dugall M, Buccella S, Kleyweght S, Cacchio M. Angiology 2001, 52(2):15-18
  36. Cesarone MR, Belcaro G, Rulo A, Griffin M, Ricci A, Ippolito E, De Sanctis MT, Incandela L, Bavera P, Cacchio M, Bucci M. Angiology 2001, 52(2):45-8
  37. Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Grimaldi R, Marelli C, Belcaro G. Minerva Cardioangiol 1994, 42(6):299-304 [Italian]
  38. Incandela L, Cesarone MR, Cacchio M, De Sanctis MT, Santavenere C, D’Auro MG, Bucci M, Belcaro G. Angiology 2001a, 52(2):9-13
  39. Incandela L, Belcaro G, De Sanctis MT, Cesarone MR, Griffin M, Ippolito E, Bucci M, Cacchio M. Angiology 2001b, 52(2):61-7
  40. Incandela L, Belcaro G, Nicolaides AN, Cesarone MR, De Sanctis MT, Corsi M, Bavera P, Ippolito E, Griffin M, Geroulakos G, Sabetai M, Ramaswami G, Veller M. Angiology 2001c, 52(2):69-73
  41. Marastoni F, Baldo A, Redaelli G, Ghiringhelli L. Minerva Cardioangiol 1982, 30(4):201-7 [Italian]
  42. Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Cochrane Database Syst Rev 2005, 20(3):CD003229
  43. Pointel JP, Boccalon H, Cloarec M, Ledevehat C, Joubert M. Angiology 1987, 38(1):46-50
  44. Wollina U, Abdel-Naser MB, Mani R. 2006, 5:169-80
  45. Alternative Medicine Review. 2007.  12:1, 69-72. 
  46. Asakawa Y, Matsuda R, Takemoto T. Phytochemistry 1982, 21:2590-2
  47. Barnes J, Anderson LA and Phillipson JD. Herbal Medicines. 3rd ed. Pharmaceutical press, London 2007, 371-73
  48. Basset A. A new Acquisition in Dermatology – the fatty gauze Madécassol. La Vie Medicale 1978, 2-4
  49. Bhandari P, Kumar N, Gupta AP, Singh B, Kaul VK. J Sep Sci 2007, 30:2092-6
  50. Brinkhaus B, Linder M, Schuppan D, Hahn EG.  Phytomedicine 2000, 7:427-48
  51. British Herbal Pharmacopoeia. British Herbal Medicine Association. Exeter 1983, 56-7
  52. Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. I. Indian J Exp Biol 1968, 6:232-47.
  53. EMEA. The Committee for Veterinary Medicinal Products.  EMEA/MRL/494 September 1998
  54. ESCOP Monographs 2nd ed. Supplement 2009. European Scientific Cooperative on Phytotherapy, editor. Thieme, Stuttgart 2009
  55. Inamdar PK, Yeole RD, Ghogare AB, de Souza NJ. J Chrom A 1996, 742:127-30
  56. Kartnig T. Clinical applications of Centella asiatica (L.). Herbs Spices Med Plants 1988, 3:145-73
  57. Mohandas Rao KG, Muddanna Rao S, Gurumadhva Rao S. Centella asiatica (L.) Evid Based Compl Alter Med 2006, 3:349-57
  58. Rotblatt M, Ziment I. Hanley & Belfus inc. Medical Publishers, Philadelphia 2001, 227-30
  59. Sahu NP, Subodh KR, Mahato SB. Phytochemistry 1989, 28: 2852-54.
  60. Sathya B, Uthaya Ganga R. 2007. Available at: http://openmed.nic.in
  61. Subban R, Veerakumar A, Manimaran R, Hashim KM, Balachandran I. J Nat Med 2008, 62:369-73
  62. Tiwari KN, Sharma NC, Tiwari V, Singh BD. Plant Cell, Tissue and Organ Culture 2000, 63:179-85
  63. WHO monographs on selected medicinal plants. World Health Organization, Geneva 1999
  64. Williamson EM. Potter’s Cyclopaedia of Botanical Drugs and Preparations. The C.W. Daniel Company Ltd, Essex, England 2003, 229-30
  65. A. vera extract. Full Study: Radha MH, Laxmipriya NP.  J Tradit Complement Med. 2015;5(1):21-6.
  66. Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. Trop Med Int Health. 1996;1(4):505-9.
  67. Vardy DA, Cohen AD, Tchetov T, Medvedovsky E, Biton A. J Dermatological Treatment. 1999;10(1):7-11.
  68. Visuthikosol V, Chowchuen B, Sukwanarat Y, Sriurairatana S, Boonpucknavig V. J Med Association Thailand. 1995;78(8):403-9.
  69. Grindlay D, Reynolds T.  J Ethnopharmacol. 1986; 16(2–3): 117–51.
  70. Little JW. Complementary and alternative medicine: impact on dentistry.  2004; 98: 137–45. 
  71. Morton JF. Econ Bot. 1961; 15: 311–19.
  72. Ahlawat KS, Khatkar BS. 2011; 48: 525–33. 
  73. Hamman JH. Molecules. 2008; 13: 1599–616.
  74. Gupta VK, Malhotra S.  Ayu. 2012; 33(2): 193–6. 
  75. Ghaderi R, Afshar M, Akhbarie H, Golalipour MJ. Int J Morphol. 2010; 28(1): 193–198.
  76. Blanks T. Mind, Body, and Soul: Body Shop Book of Wellbeing. Ebury Press. London, 1998.
  77. Reynolds T, Dweck AC.  J Ethnopharmacol. 1999; 68: 3–37. 
  78. Boudreau MD, Beland FA.  Rev. 2006; 24(1): 103–54. 
  79. Molazem Z, Mohseni F, Younesi M, Keshavarzi S. Glob J Health Sci. 2014; 7(1): 203–9. 
  80. Paulsen E, Korsholm L, Brandrup F.  J Eur Acad Dermatol Venereol. 2005; 19(3): 326–31. 
  81. Panahi Y, Sharif MR, Sharif A, Beiraghdar F, Zahiri Z, Amirchoopani G, et al.  Scientific World Journal. 2012; 2012: 810234. 
  82. Reuter J, Jocher A, Stump J, Grossjohann B, Franke G, Schempp CM. Skin Pharmacol Physiol. 2008; 21(2): 106–110. 
  83. Bhattacharya M, Kaur I, Kumar B. J Dermatol. 2000; 27: 576–82. 
  84. Rajar UD, Majeed R, Parveen N, Sheikh I, Sushel C. J Coll Physicians Surg Pak. 2008; 18(10): 612–4. 
  85. Tanaka M, Misawa E, Ito Y, Habara N, Nomaquchi K, Yamada M, et al. Biol Pharm Bull. 2006; 29(7): 1418–22. 
  86. Tanaka M, Misawa E, Yamauchi K, Abe F, Ishizaki C. Clin Cosmet Investig Dermatol. 2015; 8: 95–104.
  87. West DP, Zhu YF.  Am J Infect Control. 2003; 31(1): 40–2.
  88. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Arch Dermatol. 2002; 138(11): 1462–70. 
  89. Cho S, Lee S, Lee MJ, Lee DH, Won CH, Kim SM, et al.  Ann Dermatol. 2009; 21(1): 6–11. 
  90. Tatakis DN, Kumar PS.  Dent Clin North Am. 2005; 49(3): 491–516. 
  91. Gupta S, Jawanda MK. Indian J Dermatol. 2015; 60(3): 222–229. 
  92. Sugerman PB, Savage NW, Zhou X, Walsh LJ, Bigby M. Clin Dermatol. 2000; 18: 533–9. 
  93. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P.  Br J Dermatol. 2008; 158(3): 573–7. 
  94. Salazar-Sánchez N, López-Jornet P, Camacho-Alonso F, Sánchez-Siles M.  2010; 39(10): 735–40. 
  95. Altenburg A, Zouboulis CC. Skin Therapy Lett. 2008; 13(7): 1–4.
  96. Babaee N, Zabihi E, Mohseni S, Moghadamnia AA. Dent Res J. 2012; 9(4): 381–5.
  97. Vangipuram S, Jha A, Bhashyam M. J Clin Exp Dent. 2016; 8(4): e442-e447.
  98. de Oliveira SM, Torres TC, Pereira SL, Mota OM, Carlos MX. J Appl Oral Sci. 2008; 16(4): 293–6. 
  99. Chandrahas B, Jayakumar A, Naveen A, Butchibabu K, Reddy PK, Muralikrishna T. J Indian Soc Periodontol. 2012; 16(4): 543–8.
  100. Warnakulasuriya S, Johnson NW, van der Waal I. J Oral Pathol Med. 2007; 36(10): 575–80. 
  101. Sudarshan R, Annigeri RG, SreeVijayabala G.  J Oral Pathol Med. 2012; 41(10): 755–61. 
  102. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Crit Rev Oral Biol Med. 2003; 14(4): 275–91. 
  103. López-Jornet P, Camacho-Alonso F, Molino-Pagan D. J Oral Pathol Med. 2013; 42(4): 295–301. 
  104. Saha L. World J Gastroenterol. 2014; 20(22): 6759–73. 
  105. Davis K, Philpott S, Kumar D, Mendall M.  Int J Clin Pract. 2006; 60(9): 1080–6. 
  106. Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, et al.  Aliment Pharmacol Ther. 2004; 19(7): 739–47. 
  107. Ryan JL. J Invest Dermatol. 2012; 132(3): 985–93. 
  108. Haddad P, Amouzgar-Hashemi F, Samsami S, Chinichian S, Oghabian MA. Curr Oncol. 2013; 20(4): e345–8. 
  109. Puataweepong P, Dhanachai M, Dangprasert S, Sithatani C, Sawangsilp T, NarkwongL, et al. Asian Biomed. 2009; 3(4): 375–82.
  110. Merchant TE, Bosley C, Smith J, Baratti P, Pritchard D, Davis T, et al. Radiat Oncol. 2007; 2: 45. 
  111. Mansouri P, Haghighi M, Beheshtipour N, Ramzi M.  Int J Community Based Nurs Midwifery. 2016; 4(2): 119–26.
  112. Wild S, Roglic G, Green A, Sicree R, King H.  Diabetes Care. 2004; 27(5): 1047–53. 
  113. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Phytomedicine. 1996; 3(3): 241–3. 
  114. Yagi A, Hegazy S, Kabbash A, Wahab EA.  Saudi Pharm J. 2009; 17(3): 209–15. 
  115. Tanzer JM, Livingston J, Thompson AM.  J Dent Educ. 2001; 65(10): 1028–37.
  116. Bhati N, Jaidka S, Somani R.  J Int Soc Prev Community Dent. 2015; 5(5): 394–9.
  117. Prabhakkar AR, Karuna YM, Yavagal C, Deepak BM.  Contemp Clin Dent. 2015; 6(1): S24–31.
  118. Ånséhn, S. 1990.  Swed. J. Biol. Med. 2:5-8.
  119. Arweiler, N. B., N. Donos, L. Netuschil, E. Reich, and A. Sculean. 2000.  Clin. Oral Investig. 4:70-73.
  120. Aspres, N., and S. Freeman. 2003. Exogenous Dermatol. 2:258-261.
  121. Banes-Marshall, L., P. Cawley, and C. A. Phillips. 2001. Br. J. Biomed. Sci. 58:139-145.
  122. Bassett, I. B., D. L. Pannowitz, and R. S. Barnetson. 1990.  Med. J. Aust. 153:455-458.
  123. Beylier, M. F. 1979.  Perfum. Flavourist 4:23-25.
  124. Biju, S. S., A. Ahuja, R. K. Khar, and R. Chaudhry. 2005.  Pharmazie 60:208-211.
  125. Bischoff, K., and F. Guale. 1998. J. Vet. Diagn. Investig. 10:208-210.
  126. Bishop, C. D. 1995.  J. Essent. Oil Res. 7:641-644.
  127. Blackwell, A. L. 1991. Lancet 337:300.
  128. Blackwell, R. 1991.  Br. J. Phytother. 2:26-30.
  129. Bourne, K. Z., N. Bourne, S. F. Reising, and L. R. Stanberry. 1999.  Antiviral Res. 42:219-226.
  130. Brand, C., M. A. Grimbaldeston, J. R. Gamble, J. Drew, J. J. Finlay-Jones, and P. H. Hart. 2002.  Inflamm. Res. 51:236-244.
  131. Brand, C., S. L. Townley, J. J. Finlay-Jones, and P. H. Hart. 2002. Inflamm. Res. 51:283-289.
  132. Buck, D. S., D. M. Nidorf, and J. G. Addino. 1994.  J. Fam. Pract. 38:601-605.
  133. Caelli, M., J. Porteous, C. F. Carson, R. Heller, and T. V. Riley. 2000. J. Hosp. Infect. 46:236-237.
  134. Caldefie-Chézet, F., M. Guerry, J. C. Chalchat, C. Fusillier, M. P. Vasson, and J. Guillot. 2004. Res. 38:805-811.
  135. Carson, C. F., L. Ashton, L. Dry, D. W. Smith, and T. V. Riley. 2001. J. Antimicrob. Chemother. 48:450-451.
  136. Carson, C. F., B. D. Cookson, H. D. Farrelly, and T. V. Riley. 1995.  J. Antimicrob. Chemother. 35:421-424.
  137. Carson, C. F., K. A. Hammer, and T. V. Riley. 1995.  Microbios 82:181-185.
  138. Carson, C. F., K. A. Hammer, and T. V. Riley. 1996. J. Antimicrob. Chemother. 37:1177-1178.
  139. Carson, C. F., B. J. Mee, and T. V. Riley. 2002.  Antimicrob. Agents Chemother. 48:1914-1920. [PMC free article]
  140. Carson, C. F., and T. V. Riley. 1993. Lett. Appl. Microbiol. 16:49-55.
  141. Carson, C. F., and T. V. Riley. 1995. J. Appl. Bacteriol. 78:264-269.
  142. Carson, C. F., and T. V. Riley. 1994.  Lett. Appl. Microbiol. 19:24-25.
  143. Cassella, S., J. P. Cassella, and I. Smith. 2002.  Int. J. Aromather. 12:2-15.
  144. Chan, C. H., and K. W. Loudon. 1998.  J. Hosp. Infect. 39:244-245.
  145. Chand, S., I. Lusunzi, D. A. Veal, L. R. Williams, and P. Caruso. 1994. J. Antibiot. 47:1295-1304.
  146. Chao, S. C., D. G. Young, and C. J. Oberg. 2000.  J. Essent. Oil Res. 12:639-649.
  147. Christoph, F., P. M. Kaulfers, and E. Stahl-Biskup. 2000. Planta Med. 66:556-560.
  148. Christoph, F., P. M. Kaulfers, and E. Stahl-Biskup. 2001.  Planta Med. 67:768-771.
  149. Christoph, F., E. Stahl-Biskup, and P. M. Kaulfers. 2001.  J. Essent. Oil Res. 13:98-102.
  150. Cox, S. D., J. E. Gustafson, C. M. Mann, J. L. Markham, Y. C. Liew, R. P. Hartland, H. C. Bell, J. R. Warmington, and S. G. Wyllie. 1998.  Lett. Appl. Microbiol. 26:355-358.
  151. Cox, S. D., C. M. Mann, J. L. Markham, H. C. Bell, J. E. Gustafson, J. R. Warmington, and S. G. Wyllie. 2000. J. Appl. Microbiol. 88:170-175.
  152. Cox, S. D., C. M. Mann, J. L. Markham, J. E. Gustafson, J. R. Warmington, and S. G. Wyllie. 2001.  Molecules 6:87-91.
  153. D’Auria, F. D., L. Laino, V. Strippoli, M. Tecca, G. Salvatore, L. Battinelli, and G. Mazzanti. 2001. J. Chemother. 13:377-383.
  154. Davis, A., J. O’Leary, A. Muthaiyan, M. Langevin, A. Delgado, A. Abalos, A. Fajardo, J. Marek, B. Wilkinson, and J. Gustafson. 2005. J. Appl. Microbiol. 98:364-372. [PMC free article]
  155. De Groot, A. C., and J. W. Weyland. 1992.  Contact Dermatitis 27:279-280.
  156. Dryden, M. S., S. Dailly, and M. Crouch. 2004.  J. Hosp. Infect. 56:283-286.
  157. Elsom, G. K. F., and D. Hide. 1999.  J. Antimicrob. Chemother. 43:427-428.
  158. Ergin, A., and S. Arikan. 2002.  J. Chemother. 14:465-472.
  159. Feinblatt, H. M. 1960.  J. Natl. Med. Assoc. 52:32-34. [PMC free article]
  160. Griffin, S. G., S. G. Wyllie, J. L. Markham, and D. N. Leach. 1999. Flav. Fragr. J. 14:322-332.
  161. Groppo, F. C., J. C. Ramacciato, R. P. Simoes, F. M. Florio, and A. Sartoratto. 2002. Int. Dent. J. 52:433-437.
  162. Gustafson, J. E., S. D. Cox, Y. C. Liew, S. G. Wyllie, and J. R. Warmington. 2001. Pathology 33:211-215.
  163. Gustafson, J. E., Y. C. Liew, S. Chew, J. Markham, H. C. Bell, S. G. Wyllie, and J. R. Warmington. 1998. Effects of tea tree oil on Escherichia coli. Lett. Appl. Microbiol. 26:194-198.
  164. Hada, T., S. Furuse, Y. Matsumoto, H. Hamashima, K. Masuda, K. Shiojima, T. Arai, and M. Sasatsu. 2001. Microbios 106(Suppl. 2):133-141.
  165. Hada, T., Y. Inoue, A. Shiraishi, and H. Hamashima. 2003. J. Microbiol. Methods 53:309-312.
  166. Hammer, K. A., C. F. Carson, and T. V. Riley. 2003.  J. Appl. Microbiol. 95:853-860.
  167. Hammer, K. A., C. F. Carson, and T. V. Riley. 2004.  J. Antimicrob. Chemother. 53:1081-1085.
  168. Hammer, K. A., C. F. Carson, and T. V. Riley. 2000.   Chemother. 44:467-469. [PMC free article]
  169. Hammer, K. A., C. F. Carson, and T. V. Riley. 2002.  J. Antimicrob. Chemother. 50:195-199.
  170. Hammer, K. A., C. F. Carson, and T. V. Riley. 1999.  Antimicrob. Agents Chemother. 43:196. [PMC free article]
  171. Hammer, K. A., C. F. Carson, and T. V. Riley. 1999.  J. Appl. Microbiol. 86:446-452.
  172. Hammer, K. A., C. F. Carson, and T. V. Riley. 1998. J. Antimicrob. Chemother. 42:591-595.
  173. Hammer, K. A., C. F. Carson, and T. V. Riley. 2000.  Med. Mycol. 38:355-362.
  174. Hammer, K. A., C. F. Carson, and T. V. Riley. 1996. Am. J. Infect. Control 24:186-189.
  175. Hammer, K. A., L. Dry, M. Johnson, E. M. Michalak, C. F. Carson, and T. V. Riley. 2003. Immunol. 18:389-392.
  176. Hart, P. H., C. Brand, C. F. Carson, T. V. Riley, R. H. Prager, and J. J. Finlay-Jones. 2000.  Inflamm. Res. 49:619-626.
  177. Hausen, B. M., J. Reichling, and M. Harkenthal. 1999.  Am. J. Contact Dermatitis 10:68-77.
  178. Humphery, E. M. 1930.Med. J. Aust. 1:417-418.
  179. Inouye, S., T. Takizawa, and H. Yamaguchi. 2001. J. Antimicrob. Chemother. 47:565-573.
  180. Inouye, S., T. Tsuruoka, M. Watanabe, K. Takeo, M. Akao, Y. Nishiyama, and H. Yamaguchi. 2000. Mycoses 43:17-23.
  181. Inouye, S., K. Uchida, and H. Yamaguchi. 2001. Mycoses 44:99-107.
  182. Inouye, S., M. Watanabe, Y. Nishiyama, K. Takeo, M. Akao, and H. Yamaguchi. 1998.  Mycoses 41:403-410.
  183. Jackson, R. W., and J. A. DeMoss. 1965.  J. Bacteriol. 90:1420-1424. [PMC free article]
  184. Jandourek, A., J. K. Vaishampayan, and J. A. Vazquez. 1998. AIDS 12:1033-1037.
  185. Khalil, Z., A. L Pearce, N. Satkunanathan, E. Storer, J. J. Finlay-Jones, and P. Hart. 2004.  J. Investig. Dermatol. 123:683-690.
  186. Klimmek, J. K., R. Nowicki, K. Szendzielorz, M. Kunicka, R. Rosentrit, G. Honisz, and W. Krol. 2002.  Mikol. Lekarska 9:93-96.
  187. Knight, T. E., and B. M. Hausen. 1994.  J. Am. Acad. Dermatol. 30:423-427.
  188. Koh, K. J., A. L. Pearce, G. Marshman, J. J. Finlay-Jones, and P. H. Hart. 2002. Br. J. Dermatol. 147:1212-1217.
  189. Low, D., B. D. Rawal, and W. J. Griffin. 1974.  Planta Med. 26:184-189.
  190. Maruzzella, J. C., and N. A. Sicurella. 1960. J. Am. Pharm. Assoc. 49:692-694.
  191. May, J., C. H. Chan, A. King, L. Williams, and G. L. French. 2000. J. Antimicrob. Chemother. 45:639-643.
  192. Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005. J. Hosp. Infect. 59:113-125.
  193. Messager, S., K. A. Hammer, C. F. Carson, and T. V. Riley. 2005.  J. Hosp. Infect. 59:220-228.
  194. Minami, M., M. Kita, T. Nakaya, T. Yamamoto, H. Kuriyama, and J. Imanishi. 2003. Microbiol. Immunol. 47:681-684.
  195. Mondello, F., F. De Bernardis, A. Girolamo, G. Salvatore, and A. Cassone. 2003. J. Antimicrob. Chemother. 51:1223-1229.
  196. Morris, M. C., A. Donoghue, J. A. Markowitz, and K. C. Osterhoudt. 2003.  Pediatr. Emerg. Care 19:169-171.
  197. Murtagh, J. G. 1999. vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.
  198. Nelson, R. R. S. 2000.  J. Antimicrob. Chemother. 45:549-550.
  199. Nelson, R. R. S. 1997.  J. Antimicrob. Chemother. 40:305-306.
  200. Nenoff, P., U.-F. Haustein, and W. Brandt. 1996. Skin Pharmacol. 9:388-394.
  201. Oliva, B., E. Piccirilli, T. Ceddia, E. Pontieri, P. Aureli, and A. Ferrini. 2003.  Lett. Appl. Microbiol. 37:185-187.
  202. Pearce, A., J. J. Finlay-Jones, and P. H. Hart. 2005.  Inflamm. Res. 54:22-30.
  203. Peña, E. F. 1962.  Obstet. Gynecol. 19:793-795.
  204. Penfold, A. R., and R. Grant. 1925.  J. R. Soc. New South Wales 59:346-349.
  205. Penfold, A. R., and R. Grant. 1923.  J. R. Soc. New South Wales 57:80-89.
  206. Penfold, A. R., and R. Grant. 1924.  J. R. Soc. New South Wales 58:117-123.
  207. Raman, A., U. Weir, and S. F. Bloomfield. 1995.  Lett. Appl. Microbiol. 21:242-245.
  208. Reichling, J., A. Weseler, U. Landvatter, and R. Saller. 2002. Acta Phytotherapeutica 1:26-32.
  209. Rushton, R. T., N. W. Davis, J. C. Page, and C. A. Durkin. 1997.Lower Extremity 4:113-116.
  210. Russell, M. 1999. Toxicology of tea tree oil, p. 191-201. In I. Southwell and R. Lowe (ed.), Tea tree: the genus Melaleuca, vol. 9. Harwood Academic Publishers, Amsterdam, The Netherlands.
  211. Satchell, A. C., A. Saurajen, C. Bell, and R. S. Barnetson. 2002. Australas. J. Dematol. 43:175-178.
  212. Schnitzler, P., K. Schön, and J. Reichling. 2001.  Pharmazie 56:343-347.
  213. Shapiro, S., A. Meier, and B. Guggenheim. 1994.  Oral Microbiol. Immunol. 9:202-208.
  214. Shemesh, A., and W. L. Mayo. 1991.  Aust. J. Pharm. 72:802-803.
  215. Sherry, E., H. Boeck, and P. H. Warnke. 2001.  Am. J. Infect. Control 29:346.
  216. Shin, S. 2003. B. Arch. Pharmacol. Res. 26:389-393.
  217. Soukoulis, S., and R. Hirsch. 2004.  Aust. Dent. J. 49:78-83.
  218. Southwell, I. A., A. J. Hayes, J. Markham, and D. N. Leach. 1993. Acta Hort. 344:256-265.
  219. Southwell, I. A., S. Freeman, and D. Rubel. 1997.  J. Essent. Oil Res. 9:47-52.
  220. Syed, T. A., Z. A. Qureshi, S. M. Ali, S. Ahmad, and S. A. Ahmad. 1999. Trop. Med. Int. Health 4:284-287.
  221. Takarada, K. 2005. Oral Dis. 11:115.
  222. Tong, M. M., P. M. Altman, and R. S. Barnetson. 1992.  Aust. J. Dermatol. 33:145-149.
  223. Uribe, S., J. Ramirez, and A. Peña. 1985.  J. Bacteriol. 161:1195-1200. [PMC free article]
  224. Vazquez, J. A., M. T. Arganoza, D. Boikov, J. K. Vaishampayan, and R. A. Akins. 2000. Rev. Iberoam. Micol. 17:60-63.
  225. Vazquez, J. A., and A. A. Zawawi. 2002.  HIV Clin. Trials 3:379-385.
  226. Walker, M. 1972. Curr. Podiatry 1972:7-15.
  227. Walsh, L. J., and J. Longstaff. 1987. Periodontology 8:11-15.
  228. Warnke, P. H., E. Sherry, P. A. Russo, M. Sprengel, Y. Acil, J. P. Bredee, S. Schubert, J. Wiltfang, and I. Springer. 2005. J. Clin. Oncol. 23:1588-1589.
  229. Williams, L. R., V. N. Home, and I. Lusunzi. 1993. Cosmet. Aerosols Toiletries Aust. 7:25-34.